Most Read
U.K. Poised to Allow Foreign Trips to Just a Handful of Places
Trump Remains Banned on Facebook, Oversight Board Rules
The Dogecoin Joke Is Turning Serious in Latest Crypto Binge
Glaxo Defends Strategy in Face of Elliott Management Stake
Opinion
Five Ways to Speed Up Flagging U.S. Vaccination Rates
Making vaccines much easier to get is only the start.
Trump Stays Banned on Facebook. Keep It That Way.
Allowing him to return would have only been a reminder of the company's poor policing of its platform and the limited powers of its Oversight Board.
Deutsche Bank Gets the CoCo Bond Party Going Again
The German lender’s sale of the riskiest type of debt has attracted lots of interest. That’s a clear sign of confidence in Europe’s post-pandemic recovery.
Why America’s Population Advantage Has Evaporated
There are good and bad reasons, but they all add up to a grim economic future, especially for younger people.
Biden Finally Stops Lowballing Vaccine Goals
Starting with a promise to deliver 100 million shots in the first 100 days ensured an easy political win. The next steps will be riskier.
Opinion
Five Ways to Speed Up Flagging U.S. Vaccination Rates
Making vaccines much easier to get is only the start.
Trump Stays Banned on Facebook. Keep It That Way.
Allowing him to return would have only been a reminder of the company's poor policing of its platform and the limited powers of its Oversight Board.
Deutsche Bank Gets the CoCo Bond Party Going Again
The German lender’s sale of the riskiest type of debt has attracted lots of interest. That’s a clear sign of confidence in Europe’s post-pandemic recovery.
Why America’s Population Advantage Has Evaporated
There are good and bad reasons, but they all add up to a grim economic future, especially for younger people.
Biden Finally Stops Lowballing Vaccine Goals
Starting with a promise to deliver 100 million shots in the first 100 days ensured an easy political win. The next steps will be riskier.